Anne Farmer Selected Research

Nortriptyline (Aventyl)

1/2019	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
10/2018	Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
1/2016	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
12/2014	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
2/2013	Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
12/2012	Self-report and clinician-rated measures of depression severity: can one replace the other?
4/2011	Changes in body weight during pharmacological treatment of depression.
6/2010	History of suicide attempts among patients with depression in the GENDEP project.
11/2009	Body weight as a predictor of antidepressant efficacy in the GENDEP project.
9/2009	Adverse reactions to antidepressants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Farmer Research Topics

Disease

11	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 04/2009
5	Bipolar Disorder (Manic Depressive Psychosis) 12/2014 - 09/2008
4	Inflammation (Inflammations) 10/2018 - 02/2013
4	Schizophrenia (Dementia Praecox) 01/2017 - 09/2009
2	Genetic Risk Score 10/2018 - 01/2017
2	Mood Disorders (Mood Disorder) 12/2014 - 01/2007
2	Drug-Related Side Effects and Adverse Reactions 02/2014 - 09/2009
2	Body Weight (Weight, Body) 04/2011 - 11/2009
2	Depressive Disorder (Melancholia) 04/2011 - 03/2009
2	Weight Gain 04/2011 - 09/2009
2	Psychotic Disorders (Schizoaffective Disorder) 10/2010 - 04/2009
1	Anorexia Nervosa 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2014
1	Migraine Disorders (Migraine) 06/2011
1	Weight Loss (Weight Reduction) 04/2011
1	Overweight 11/2009
1	Obesity 11/2009
1	Constipation 09/2009
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2009
1	Neurobehavioral Manifestations 03/2009
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 07/2005

Drug/Important Bio-Agent (IBA)

11	Nortriptyline (Aventyl)FDA LinkGeneric 01/2019 - 03/2009
11	Escitalopram FDA Link 01/2019 - 03/2009
9	Antidepressive Agents (Antidepressants)IBA 01/2019 - 09/2009
3	C-Reactive ProteinIBA 10/2018 - 12/2014
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019 - 04/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 12/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2014 - 01/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2013 - 01/2007
2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 07/2005
2	Oxidoreductases (Dehydrogenase)IBA 06/2011 - 10/2010
1	LipidsIBA 01/2019
1	Pharmaceutical PreparationsIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Biological ProductsIBA 12/2014
1	CalciumIBA 01/2014
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2014
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013
1	InterleukinsIBA 02/2013
1	CytokinesIBA 02/2013
1	Tacrolimus Binding Proteins (FKBP)IBA 02/2013
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2011
1	5,10-methylenetetrahydrofolic acidIBA 10/2010
1	GABA-A Receptors (GABA(A) Receptor)IBA 10/2010
1	DysbindinIBA 09/2009
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 04/2009
1	Indicators and Reagents (Reagents)IBA 04/2009
1	AnkyrinsIBA 09/2008
1	TransferasesIBA 01/2007
1	catechol (pyrocatechol)IBA 01/2007
1	Tryptophan (L-Tryptophan)FDA Link 07/2005

Therapy/Procedure

3	Therapeutics 01/2018 - 07/2005
1	Deep Brain Stimulation 01/2018